{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:40:06Z","timestamp":1792136406348,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glutamatergic dysfunction is implicated in schizophrenia pathoaetiology, but this may vary in extent between patients. It is unclear whether inter-individual variability in glutamate is greater in schizophrenia than the general population. We conducted meta-analyses to assess (1) variability of glutamate measures in patients relative to controls (log coefficient of variation ratio: CVR); (2) standardised mean differences (SMD) using Hedges g; (3) modal distribution of individual-level glutamate data (Hartigan\u2019s unimodality dip test). MEDLINE and EMBASE databases were searched from inception to September 2022 for proton magnetic resonance spectroscopy (1H-MRS) studies reporting glutamate, glutamine or Glx in schizophrenia. 123 studies reporting on 8256 patients and 7532 controls were included. Compared with controls, patients demonstrated greater variability in glutamatergic metabolites in the medial frontal cortex (MFC, glutamate: CVR\u2009=\u20090.15,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; glutamine: CVR\u2009=\u20090.15,<jats:italic>p<\/jats:italic>\u2009=\u20090.003; Glx: CVR\u2009=\u20090.11,<jats:italic>p<\/jats:italic>\u2009=\u20090.002), dorsolateral prefrontal cortex (glutamine: CVR\u2009=\u20090.14,<jats:italic>p<\/jats:italic>\u2009=\u20090.05; Glx: CVR\u2009=\u20090.25,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and thalamus (glutamate: CVR\u2009=\u20090.16,<jats:italic>p<\/jats:italic>\u2009=\u20090.008; Glx: CVR\u2009=\u20090.19,<jats:italic>p<\/jats:italic>\u2009=\u20090.008). Studies in younger, more symptomatic patients were associated with greater variability in the basal ganglia (BG glutamate with age:<jats:italic>z<\/jats:italic>\u2009=\u2009\u22120.03,<jats:italic>p<\/jats:italic>\u2009=\u20090.003, symptoms:<jats:italic>z<\/jats:italic>\u2009=\u20090.007,<jats:italic>p<\/jats:italic>\u2009=\u20090.02) and temporal lobe (glutamate with age:<jats:italic>z<\/jats:italic>\u2009=\u2009\u22120.03,<jats:italic>p<\/jats:italic>\u2009=\u20090.02), while studies with older, more symptomatic patients associated with greater variability in MFC (glutamate with age:<jats:italic>z<\/jats:italic>\u2009=\u20090.01,<jats:italic>p<\/jats:italic>\u2009=\u20090.02, glutamine with symptoms:<jats:italic>z<\/jats:italic>\u2009=\u20090.01,<jats:italic>p<\/jats:italic>\u2009=\u20090.02). For individual patient data, most studies showed a unimodal distribution of glutamatergic metabolites. Meta-analysis of mean differences found lower MFC glutamate (<jats:italic>g<\/jats:italic>\u2009=\u2009\u22120.15,<jats:italic>p<\/jats:italic>\u2009=\u20090.03), higher thalamic glutamine (<jats:italic>g<\/jats:italic>\u2009=\u20090.53,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and higher BG Glx in patients relative to controls (<jats:italic>g<\/jats:italic>\u2009=\u20090.28,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Proportion of males was negatively associated with MFC glutamate (<jats:italic>z<\/jats:italic>\u2009=\u2009\u22120.02,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and frontal white matter Glx (<jats:italic>z<\/jats:italic>\u2009=\u2009\u22120.03,<jats:italic>p<\/jats:italic>\u2009=\u20090.02) in patients relative to controls. Patient PANSS total score was positively associated with glutamate SMD in BG (<jats:italic>z<\/jats:italic>\u2009=\u20090.01,<jats:italic>p<\/jats:italic>\u2009=\u20090.01) and temporal lobe (<jats:italic>z<\/jats:italic>\u2009=\u20090.05,<jats:italic>p<\/jats:italic>\u2009=\u20090.008). Further research into the mechanisms underlying greater glutamatergic metabolite variability in schizophrenia and their clinical consequences may inform the identification of patient subgroups for future treatment strategies.<\/jats:p>","DOI":"10.1038\/s41380-023-01991-7","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T14:10:42Z","timestamp":1676643042000},"page":"2039-2048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5716-4941","authenticated-orcid":false,"given":"Kate","family":"Merritt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1102-2566","authenticated-orcid":false,"given":"Robert A.","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-8237","authenticated-orcid":false,"given":"Katherine","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald J. N.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-5226","authenticated-orcid":false,"given":"Faith","family":"Borgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Boules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-8152","authenticated-orcid":false,"given":"Juan R.","family":"Bustillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-8499","authenticated-orcid":false,"given":"Aristides A.","family":"Capizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-9640","authenticated-orcid":false,"given":"Jennifer M.","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1642","authenticated-orcid":false,"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsime","family":"Demjaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1968-1646","authenticated-orcid":false,"given":"Kim Q.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-4255","authenticated-orcid":false,"given":"Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-8304","authenticated-orcid":false,"given":"Beata","family":"Gali\u0144ska-Skok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Gallinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Gasparovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric E.","family":"Ginestet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-1555","authenticated-orcid":false,"given":"Beng-Choon","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-3659","authenticated-orcid":false,"given":"Sameer","family":"Jauhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-3952","authenticated-orcid":false,"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kegeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri S.","family":"Keshavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-4567","authenticated-orcid":false,"given":"Bridget","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-3790","authenticated-orcid":false,"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Le\u00f3n-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Liemburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Mcilwain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-066X","authenticated-orcid":false,"given":"Gemma","family":"Modinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Mouchlianitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Nenadic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1640-7182","authenticated-orcid":false,"given":"Lena","family":"Palaniyappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-0238","authenticated-orcid":false,"given":"Christos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulsi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-758X","authenticated-orcid":false,"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-1068","authenticated-orcid":false,"given":"Sotirios","family":"Posporelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot E.","family":"Purdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen R.","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-4503","authenticated-orcid":false,"given":"Perry F.","family":"Renshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-4119","authenticated-orcid":false,"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-3008","authenticated-orcid":false,"given":"Akira","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-2245","authenticated-orcid":false,"given":"Dikoma C.","family":"Shungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Smesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-2030","authenticated-orcid":false,"given":"Katharine N.","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-4469","authenticated-orcid":false,"given":"Jean","family":"Th\u00e9berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Tibbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Walecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Yamasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-0532","authenticated-orcid":false,"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2939-064X","authenticated-orcid":false,"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the 1H-MRS in Schizophrenia Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19:15\u201333.","journal-title":"World Psychiatry"},{"key":"1991_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","volume":"73","author":"K Merritt","year":"2016","unstructured":"Merritt K, Egerton A, Kempton MJ, Taylor MJ, McGuire PK. Nature of glutamate alterations in schizophrenia a meta-analysis of proton magnetic resonance spectroscopy studies. JAMA Psychiatry. 2016;73:665\u201374.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR3","doi-asserted-by":"crossref","unstructured":"Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, et al. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. Mol Psychiatry. 2021; https:\/\/www.nature.com\/articles\/s41380-021-01297-6.","DOI":"10.1038\/s41380-021-01297-6"},{"key":"1991_CR4","unstructured":"Sydnor VJ, Roalf DR. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies: Implications for studies of psychosis risk. Schizophr Res. 2020; https:\/\/pubmed.ncbi.nlm.nih.gov\/32723493\/. Accessed 6 Oct 2020."},{"key":"1991_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.biopsych.2021.06.008","volume":"90","author":"J Smucny","year":"2021","unstructured":"Smucny J, Carter CS, Maddock RJ. Medial prefrontal cortex glutamate is reduced in schizophrenia and moderated by measurement quality: a meta-analysis of proton magnetic resonance spectroscopy studies. Biol Psychiatry. 2021;90:643\u201351. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322321013937.","journal-title":"Biol Psychiatry"},{"key":"1991_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","volume":"39","author":"A Marsman","year":"2013","unstructured":"Marsman A, van den Heuvel MP, Klomp DWJ, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull. 2013;39:120\u20139. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3523901&tool=pmcentrez&rendertype=abstract.","journal-title":"Schizophr Bull"},{"key":"1991_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41386-018-0236-0","volume":"44","author":"CS Legind","year":"2019","unstructured":"Legind CS, Broberg BV, Mandl RCW, Brouwer R, Anh\u00f8j SJ, Hilker R, et al. Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study. Neuropsychopharmacology. 2019;44:581\u20139. http:\/\/www.nature.com\/articles\/s41386-018-0236-0.","journal-title":"Neuropsychopharmacology"},{"key":"1991_CR8","doi-asserted-by":"crossref","unstructured":"Bustillo JR, Patel V, Jones T, Jung R, Payaknait N, Qualls C, et al. Risk-conferring glutamatergic genes and brain glutamate plus glutamine in schizophrenia. Front Psychiatry. 2017. http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00079\/full.","DOI":"10.3389\/fpsyt.2017.00079"},{"key":"1991_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.schres.2020.09.013","volume":"223","author":"A Egerton","year":"2020","unstructured":"Egerton A, Grace AA, Stone J, Bossong MG, Sand M, McGuire P. Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development. Schizophr Res. 2020;223:59\u201370. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996420304710.","journal-title":"Schizophr Res"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41537-019-0080-1","volume":"5","author":"K Merritt","year":"2019","unstructured":"Merritt K, Perez-Iglesias R, Sendt K-V, Goozee R, Jauhar S, Pepper F, et al. Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate. npj Schizophr 2019;5:12 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31371817.","journal-title":"npj Schizophr"},{"key":"1991_CR11","doi-asserted-by":"crossref","unstructured":"Merritt K, McGuire P, Egerton A. Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis. Front Psychiatry. 2013;4.","DOI":"10.3389\/fpsyt.2013.00151"},{"key":"1991_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","volume":"78","author":"K Merritt","year":"2021","unstructured":"Merritt K, McGuire PK, Egerton A, Aleman A, Block W, Bloemen OJN, et al. Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level. JAMA Psychiatry. 2021;78:667 https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2778479.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR13","unstructured":"Adams RA, Pinotsis D, Tsirlis K, Unruh L, Mahajan A, Horas AM, et al. Computational modeling of electroencephalography and functional magnetic resonance imaging paradigms indicates a consistent loss of pyramidal cell synaptic gain in schizophrenia. Biol Psychiatry. 2021; https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322321014992."},{"key":"1991_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fpsyt.2017.00066","volume":"8","author":"A Egerton","year":"2017","unstructured":"Egerton A, Bhachu A, Merritt K, McQueen G, Szulc A, McGuire P. Effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal1H-MRS studies. Front Psychiatry. 2017;8:66.","journal-title":"Front Psychiatry"},{"key":"1991_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbv151","volume":"42","author":"E Mouchlianitis","year":"2016","unstructured":"Mouchlianitis E, Bloomfield MAP, Law V, Beck K, Selvaraj S, Rasquinha N, et al. Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive. Schizophr Bull. 2016;42:744\u201352. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26683625.","journal-title":"Schizophr Bull"},{"key":"1991_CR16","doi-asserted-by":"publisher","first-page":"pyu117","DOI":"10.1093\/ijnp\/pyu117","volume":"18","author":"ME Goldstein","year":"2015","unstructured":"Goldstein ME, Anderson VM, Pillai A, Kydd RR, Russell BR. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. Int J Neuropsychopharmacol. 2015;18:pyu117\u201317. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25603859.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1991_CR17","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","volume":"75","author":"A Demjaha","year":"2014","unstructured":"Demjaha A, Egerton A, Murray RM, Kapur S, Howes OD, Stone JM, et al. Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. Biol Psychiatry. 2014;75:e11\u20133. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23890739.","journal-title":"Biol Psychiatry"},{"key":"1991_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","volume":"85","author":"Y Iwata","year":"2019","unstructured":"Iwata Y, Nakajima S, Plitman E, Caravaggio F, Kim J, Shah P, et al. Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study. Biol Psychiatry. 2019;85:596\u2013605. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30389132.","journal-title":"Biol Psychiatry"},{"key":"1991_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41386-019-0589-z","volume":"45","author":"R Tarumi","year":"2020","unstructured":"Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, et al. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology. 2020;45:632\u201340. https:\/\/pubmed.ncbi.nlm.nih.gov\/31842203\/.","journal-title":"Neuropsychopharmacology"},{"key":"1991_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neulet.2013.04.051","volume":"547","author":"A Szulc","year":"2013","unstructured":"Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, et al. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia. Neurosci Lett. 2013;547:37\u201341. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23665527.","journal-title":"Neurosci Lett"},{"key":"1991_CR21","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","volume":"23","author":"A Egerton","year":"2018","unstructured":"Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1 H-MRS study (OPTiMiSE). Mol Psychiatry. 2018;23:2145\u201355.","journal-title":"Mol Psychiatry"},{"key":"1991_CR22","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/npp.2012.113","volume":"37","author":"A Egerton","year":"2012","unstructured":"Egerton A, Brugger S, Raffin M, Barker GJ, Lythgoe DJ, McGuire PK, et al. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology. 2012;37:2515\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"1991_CR23","doi-asserted-by":"crossref","unstructured":"Egerton A, Murphy A, Donocik J, Anton A, Barker GJ, Collier T, et al. Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance spectroscopy study (STRATA). Schizophr Bull. 2020; https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article\/doi\/10.1093\/schbul\/sbaa128\/5903699.","DOI":"10.1093\/schbul\/sbaa128"},{"key":"1991_CR24","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1017\/S0033291719002277","volume":"50","author":"KB Bojesen","year":"2020","unstructured":"Bojesen KB, Ebdrup BH, Jessen K, Sigvard A, Tangmose K, Edden RAE, et al. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-na\u00efve patients with psychosis. Psychol Med. 2020;50:2182\u201393. https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291719002277\/type\/journal_article.","journal-title":"Psychol Med"},{"key":"1991_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","volume":"78","author":"BJ Kinon","year":"2015","unstructured":"Kinon BJ, Millen BA, Zhang L, McKinzie DL. Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia. Biol Psychiatry. 2015;78:754\u201362. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322315002541.","journal-title":"Biol Psychiatry"},{"key":"1991_CR26","doi-asserted-by":"crossref","unstructured":"Palaniyappan L, Sabesan P, Li X, Luo Q. Schizophrenia increases variability of the central antioxidant system: a meta-analysis of variance from MRS studies of glutathione. Front Psychiatry. 2021;12. https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.796466\/full.","DOI":"10.3389\/fpsyt.2021.796466"},{"key":"1991_CR27","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41380-019-0502-5","volume":"26","author":"RA McCutcheon","year":"2021","unstructured":"McCutcheon RA, Pillinger T, Mizuno Y, Montgomery A, Pandian H, Vano L, et al. The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis. Mol Psychiatry. 2021;26:1310\u201320. http:\/\/www.nature.com\/articles\/s41380-019-0502-5.","journal-title":"Mol Psychiatry"},{"key":"1991_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","volume":"74","author":"SP Brugger","year":"2017","unstructured":"Brugger SP, Howes OD. Heterogeneity and homogeneity of regional brain structure in schizophrenia. JAMA Psychiatry. 2017;74:1104 http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2017.2663.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR29","doi-asserted-by":"crossref","unstructured":"Kaminski J, Mascarell-Maricic L, Fukuda Y, Katthagen T, Heinz A, Schlagenhauf F. Glutamate in the dorsolateral prefrontal cortex in patients with schizophrenia: a meta-analysis of 1H-magnetic resonance spectroscopy studies. Biol Psychiatry. 2020;89:270\u20137.","DOI":"10.1016\/j.biopsych.2020.09.001"},{"key":"1991_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1214\/aos\/1176346577","volume":"13","author":"JA Hartigan","year":"1985","unstructured":"Hartigan JA, Hartigan PM. The dip test of unimodality. Ann Stat. 1985;13:70\u201384. http:\/\/www.jstor.org\/stable\/2241144.","journal-title":"Ann Stat"},{"key":"1991_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/wps.20893","volume":"20","author":"RA McCutcheon","year":"2021","unstructured":"McCutcheon RA, Merritt K, Howes OD. Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls. World Psychiatry. 2021;20:405\u201316. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34505389.","journal-title":"World Psychiatry"},{"key":"1991_CR32","unstructured":"Merritt K, McCutcheon R variability. 2023; https:\/\/github.com\/katemerritt\/variability\/."},{"key":"1991_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135. http:\/\/link.springer.com\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"1991_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","volume":"83","author":"C de la Fuente-Sandoval","year":"2018","unstructured":"de la Fuente-Sandoval C, Reyes-Madrigal F, Mao X, Le\u00f3n-Ortiz P, Rodr\u00edguez-Mayoral O, Jung-Cook H, et al. Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients. Biol Psychiatry. 2018;83:475\u201383. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29132653.","journal-title":"Biol Psychiatry"},{"key":"1991_CR35","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41386-020-0707-y","volume":"45","author":"JR Bustillo","year":"2020","unstructured":"Bustillo JR, Upston J, Mayer EG, Jones T, Maudsley AA, Gasparovic C, et al. Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study. Neuropsychopharmacology. 2020;45:1851\u20139. http:\/\/www.nature.com\/articles\/s41386-020-0707-y.","journal-title":"Neuropsychopharmacology"},{"key":"1991_CR36","doi-asserted-by":"crossref","unstructured":"Bustillo JR, Mayer EG, Upston J, Jones T, Garcia C, Sheriff S, et al. Increased glutamate plus glutamine in the right middle cingulate in early schizophrenia but not in bipolar psychosis: a whole brain 1H-MRS study. Front Psychiatry. 2021;12. https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.660850\/full.","DOI":"10.3389\/fpsyt.2021.660850"},{"key":"1991_CR37","doi-asserted-by":"publisher","first-page":"e21685","DOI":"10.1371\/journal.pone.0021685","volume":"6","author":"F da Silva Alves","year":"2011","unstructured":"da Silva Alves F, Boot E, Schmitz N, Nederveen A, Vorstman J, Lavini C, et al. Proton magnetic resonance spectroscopy in 22q11 deletion syndrome. PLoS One. 2011;6:e21685 http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3128078&tool=pmcentrez&rendertype=abstract.","journal-title":"PLoS One"},{"key":"1991_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor Package. J Stat Softw. 2010;36:1\u201348. https:\/\/www.jstatsoft.org\/index.php\/jss\/article\/view\/v036i03.","journal-title":"J Stat Softw"},{"key":"1991_CR39","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag New York; 2009. http:\/\/ggplot2.org.","DOI":"10.1007\/978-0-387-98141-3"},{"key":"1991_CR40","first-page":"119","volume":"8","author":"N Goto","year":"2012","unstructured":"Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K, et al. Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia. Neuropsychiatr Dis Treat. 2012;8:119\u201322.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1991_CR41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","volume":"40","author":"T Natsubori","year":"2014","unstructured":"Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, et al. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia. Schizophr Bull. 2014;40:1128\u201339. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24023251.","journal-title":"Schizophr Bull"},{"key":"1991_CR42","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","volume":"159","author":"J Theberge","year":"2002","unstructured":"Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 2002;159:1944\u20136.","journal-title":"Am J Psychiatry"},{"key":"1991_CR43","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","volume":"160","author":"J Th\u00e9berge","year":"2003","unstructured":"Th\u00e9berge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RWJ, Rajakumar N, et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured. Am J Psychiatry. 2003;160:2231\u20133. http:\/\/journals.psychiatryonline.org\/article.aspx?articleid=176549.","journal-title":"Am J Psychiatry"},{"key":"1991_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.schres.2007.05.008","volume":"94","author":"SJ Wood","year":"2007","unstructured":"Wood SJ, Y\u00fccel M, Wellard RM, Harrison BJ, Clarke K, Fornito A, et al. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. Schizophr Res. 2007;94:328\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17574388.","journal-title":"Schizophr Res"},{"key":"1991_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mrm.24291","volume":"69","author":"PG Tibbo","year":"2013","unstructured":"Tibbo PG, Bernier D, Hanstock CC, Seres P, Lakusta B, Purdon SE. 3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine. Magn Reson Med. 2013;69:613\u201320. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22511463.","journal-title":"Magn Reson Med"},{"key":"1991_CR46","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/mp.2009.121","volume":"15","author":"JR Bustillo","year":"2010","unstructured":"Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, et al. 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry. 2010;15:629\u201336. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2892215&tool=pmcentrez&rendertype=abstract.","journal-title":"Mol Psychiatry"},{"key":"1991_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamapsychiatry.2013.3939","volume":"71","author":"JR Bustillo","year":"2014","unstructured":"Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C, et al. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. JAMA Psychiatry. 2014;71:265\u201372. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24402128.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1566524015666150303104811","volume":"15","author":"JM Coughlin","year":"2015","unstructured":"Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, et al. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia. Curr Mol Med. 2015;15:176\u201383. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25732147.","journal-title":"Curr Mol Med"},{"key":"1991_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WNR.0000000000000309","volume":"26","author":"R Taylor","year":"2015","unstructured":"Taylor R, Schaefer B, Densmore M, Neufeld RWJ, Rajakumar N, Williamson PC, et al. Increased glutamate levels observed upon functional activation in the anterior cingulate cortex using the Stroop Task and functional spectroscopy. Neuroreport. 2015;26:107\u201312. http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00001756-201502010-00002.","journal-title":"Neuroreport"},{"key":"1991_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2010.05.016","volume":"68","author":"D Ong\u00fcr","year":"2010","unstructured":"Ong\u00fcr D, Prescot AP, McCarthy J, Cohen BM, Renshaw PF. Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiatry. 2010;68:667\u201370. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2942977&tool=pmcentrez&rendertype=abstract.","journal-title":"Biol Psychiatry"},{"key":"1991_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/schbul\/sbv124","volume":"42","author":"J Gallinat","year":"2016","unstructured":"Gallinat J, McMahon K, K\u00fchn S, Schubert F, Schaefer M. Cross-sectional study of glutamate in the anterior cingulate and hippocampus in schizophrenia. Schizophr Bull. 2016;42:425\u201333. https:\/\/academic.oup.com\/schizophreniabulletin\/article-lookup\/doi\/10.1093\/schbul\/sbv124.","journal-title":"Schizophr Bull"},{"key":"1991_CR52","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/schbul\/sbw038","volume":"42","author":"L Xin","year":"2016","unstructured":"Xin L, Mekle R, Fournier M, Baumann PS, Ferrari C, Alameda L, et al. Genetic polymorphism associated prefrontal glutathione and its coupling with brain glutamate and peripheral redox status in early psychosis. Schizophr Bull. 2016;42:1185\u201396. https:\/\/academic.oup.com\/schizophreniabulletin\/article-lookup\/doi\/10.1093\/schbul\/sbw038.","journal-title":"Schizophr Bull"},{"key":"1991_CR53","unstructured":"Smesny S, Gussew A, Biesel NJ, Schack S, Walther M, Rzanny R, et al. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients. Schizophr Res. 2015; http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26255566. Accessed 11 Aug 2015."},{"key":"1991_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep21873","volume":"6","author":"E Liemburg","year":"2016","unstructured":"Liemburg E, Sibeijn-Kuiper A, Bais L, Pijnenborg G, Knegtering H, van der Velde J, et al. Prefrontal NAA and Glx levels in different stages of psychotic disorders: a 3T 1H-MRS study. Sci Rep. 2016;6:21873 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26903078.","journal-title":"Sci Rep"},{"key":"1991_CR55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/archgenpsychiatry.2011.1519","volume":"69","author":"LS Kegeles","year":"2012","unstructured":"Kegeles LS, Mao XL, Stanford AD, Girgis R, Ojeil N, Xu XY, et al. Elevated prefrontal cortex \u03b3-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2012;69:449\u201359. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22213769.","journal-title":"Arch Gen Psychiatry"},{"key":"1991_CR56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopsych.2017.08.022","volume":"83","author":"S-Y Kim","year":"2018","unstructured":"Kim S-Y, Kaufman MJ, Cohen BM, Jensen JE, Coyle JT, Du F, et al. In vivo brain glycine and glutamate concentrations in patients with first-episode psychosis measured by echo time\u2013averaged proton magnetic resonance spectroscopy at 4T. Biol Psychiatry. 2018;83:484\u201391. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29031411.","journal-title":"Biol Psychiatry"},{"key":"1991_CR57","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","volume":"64","author":"D Ong\u00fcr","year":"2008","unstructured":"Ong\u00fcr D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry. 2008;64:718\u201326. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2577764&tool=pmcentrez&rendertype=abstract.","journal-title":"Biol Psychiatry"},{"key":"1991_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45018-0","volume":"9","author":"FR Borgan","year":"2019","unstructured":"Borgan FR, Jauhar S, McCutcheon RA, Pepper FS, Rogdaki M, Lythgoe DJ, et al. Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study. Sci Rep. 2019;9:8685 http:\/\/www.nature.com\/articles\/s41598-019-45018-0.","journal-title":"Sci Rep"},{"key":"1991_CR59","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2215-0366(18)30268-2","volume":"5","author":"S Jauhar","year":"2018","unstructured":"Jauhar S, McCutcheon R, Borgan F, Veronese M, Nour M, Pepper F, et al. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study. Lancet Psychiatry. 2018;5:816\u201323.","journal-title":"Lancet Psychiatry"},{"key":"1991_CR60","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-020-0704-x","volume":"25","author":"K Dempster","year":"2020","unstructured":"Dempster K, Jeon P, MacKinley M, Williamson P, Th\u00e9berge J, Palaniyappan L. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate. Mol Psychiatry. 2020;25:1640\u201350.","journal-title":"Mol Psychiatry"},{"key":"1991_CR61","first-page":"248","volume":"3","author":"S Posporelis","year":"2018","unstructured":"Posporelis S, Coughlin JM, Marsman A, Pradhan S, Tanaka T, Wang H, et al. Decoupling of brain temperature and glutamate in recent onset of schizophrenia: a 7T proton magnetic resonance spectroscopy study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:248\u201354. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451902217300873.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"1991_CR62","first-page":"CR82","volume":"15","author":"B Gali\u0144ska","year":"2009","unstructured":"Gali\u0144ska B, Szulc A, Taras\u00f3w E, Kubas B, Dzienis W, Czernikiewicz A, et al. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Med Sci Monit. 2009;15:CR82\u2013R88. http:\/\/www.medscimonit.com\/abstract\/index\/idArt\/869559.","journal-title":"Med Sci Monit"},{"key":"1991_CR63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0925-4927(00)00044-5","volume":"98","author":"LS Kegeles","year":"2000","unstructured":"Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, et al. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res Neuroimaging. 2000;98:163\u201375. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492700000445.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"1991_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0031-1279739","volume":"44","author":"A Szulc","year":"2011","unstructured":"Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, et al. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment. Pharmacopsychiatry. 2011;44:148\u201357. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21710405.","journal-title":"Pharmacopsychiatry"},{"key":"1991_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2008.03.012","volume":"102","author":"SJ Wood","year":"2008","unstructured":"Wood SJ, Berger GE, Wellard RM, Proffitt T, McConchie M, Velakoulis D, et al. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-na\u00efve and early-treated first episode psychosis. Schizophr Res. 2008;102:163\u201370. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18456460.","journal-title":"Schizophr Res"},{"key":"1991_CR66","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00213-019-5188-5","volume":"236","author":"T Pillinger","year":"2019","unstructured":"Pillinger T, Rogdaki M, McCutcheon RA, Hathway P, Egerton A, Howes OD. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications. Psychopharmacology. 2019;236:1985\u201397. http:\/\/link.springer.com\/10.1007\/s00213-019-5188-5.","journal-title":"Psychopharmacology"},{"key":"1991_CR67","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/schbul\/sbaa156","volume":"47","author":"G McQueen","year":"2021","unstructured":"McQueen G, Sendt K-V, Gillespie A, Avila A, Lally J, Vallianatou K, et al. Changes in brain glutamate on switching to clozapine in treatment-resistant schizophrenia. Schizophr Bull. 2021;47:662\u201371. https:\/\/academic.oup.com\/schizophreniabulletin\/article\/47\/3\/662\/6063097.","journal-title":"Schizophr Bull"},{"key":"1991_CR68","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","volume":"70","author":"C de la Fuente-Sandoval","year":"2013","unstructured":"de la Fuente-Sandoval C, Le\u00f3n-Ortiz P, Azc\u00e1rraga M, Stephano S, Favila R, D\u00edaz-Galvis L, et al. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. JAMA Psychiatry. 2013;70:1057\u201366. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3790718&tool=pmcentrez&rendertype=abstract.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR69","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.neubiorev.2013.06.007","volume":"37","author":"A Brouwer","year":"2013","unstructured":"Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case\u2013control studies. Neurosci Biobehav Rev. 2013;37:1587\u201396.","journal-title":"Neurosci Biobehav Rev"},{"key":"1991_CR70","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jpsychires.2010.03.003","volume":"44","author":"D Martins-de-Souza","year":"2010","unstructured":"Martins-de-Souza D, Schmitt A, R\u00f6der R, Lebar M, Schneider-Axmann T, Falkai P, et al. Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J Psychiatr Res. 2010;44:989\u201391.","journal-title":"J Psychiatr Res"},{"key":"1991_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.schres.2015.01.025","volume":"167","author":"GC Bristow","year":"2015","unstructured":"Bristow GC, Bostrom JA, Haroutunian V, Sodhi MS. Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. Schizophr Res. 2015;167:57\u201363.","journal-title":"Schizophr Res"},{"key":"1991_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamapsychiatry.2020.1941","volume":"78","author":"DR Weinberger","year":"2021","unstructured":"Weinberger DR, Radulescu E. Structural magnetic resonance imaging all over again. JAMA Psychiatry. 2021;78:11 https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2768031.","journal-title":"JAMA Psychiatry"},{"key":"1991_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41537-019-0080-1","volume":"5","author":"K Merritt","year":"2019","unstructured":"Merritt K, Perez-Iglesias R, Sendt K-V, Goozee R, Jauhar S, Pepper F, et al. Remission from antipsychotic treatment in first-episode psychosis related to longitudinal changes in brain glutamate. npj Schizophr. 2019;5:12.","journal-title":"npj Schizophr"},{"key":"1991_CR74","doi-asserted-by":"publisher","first-page":"110473","DOI":"10.1016\/j.pnpbp.2021.110473","volume":"113","author":"F Reyes-Madrigal","year":"2022","unstructured":"Reyes-Madrigal F, Guma E, Le\u00f3n-Ortiz P, G\u00f3mez-Cruz G, Mora-Dur\u00e1n R, Graff-Guerrero A, et al. Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2022;113:110473 https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621002323.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01991-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T14:08:02Z","timestamp":1728914882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-01991-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RM has received honoraria for talks from Otsuka and Janssen. OH is a part-time employee and stock holder of Lundbeck A\/s. He has received investigator-initiated research funding from and\/or participated in advisory\/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris\/Mylan. OH has a patent for the use of dopaminergic imaging.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}